Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

Heinz Drexel; Stuart J Pocock; Basil S Lewis; Christoph H Saely; Juan Carlos Kaski; Giuseppe M C Rosano; Gerda Tautermann; Kurt Huber; Joern F Dopheide; Arthur Mader; Alexander Niessner; Gianluigi Savarese; Thomas A Schmidt; Anne Grete Semb; Juan Tamargo; Sven Wassmann; Martin Clodi; Keld Per Kjeldsen; Stefan Agewall

doi:10.1093/ehjcvp/pvab048

Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

Heinz Drexel, Stuart J Pocock, Basil S Lewis, Christoph H Saely, Juan Carlos Kaski, Giuseppe M C Rosano, Gerda Tautermann, Kurt Huber, Joern F Dopheide, Arthur Mader, Alexander Niessner, Gianluigi Savarese, Thomas A Schmidt, Anne Grete Semb, Juan Tamargo, Sven Wassmann, Martin Clodi, Keld Per Kjeldsen, Stefan Agewall

Original language	English
Article number	pvab048
Journal	European heart journal. Cardiovascular pharmacotherapy
Volume	8
Issue number	3
Pages (from-to)	302-310
Number of pages	9
ISSN	2055-6837
DOIs	https://doi.org/10.1093/ehjcvp/pvab048
Publication status	Published - 5 May 2022

Keywords

Randomized clinical trials
Subgroup analyses
Cardiovascular pharmacotherapy
Humans
Cardiovascular System
Randomized Controlled Trials as Topic

Access to Document

10.1093/ehjcvp/pvab048

Cite this

Drexel, H., Pocock, S. J., Lewis, B. S., Saely, C. H., Kaski, J. C., Rosano, G. M. C., Tautermann, G., Huber, K., Dopheide, J. F., Mader, A., Niessner, A., Savarese, G., Schmidt, T. A., Semb, A. G., Tamargo, J., Wassmann, S., Clodi, M., Kjeldsen, K. P., & Agewall, S. (2022). Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy, 8(3), 302-310. [pvab048]. https://doi.org/10.1093/ehjcvp/pvab048

Subgroup analyses in randomized clinical trials : Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. / Drexel, Heinz; Pocock, Stuart J; Lewis, Basil S et al.

In: European heart journal. Cardiovascular pharmacotherapy, Vol. 8, No. 3, pvab048, 05.05.2022, p. 302-310.

Research output: Contribution to journal › Review › peer-review

Drexel, H, Pocock, SJ, Lewis, BS, Saely, CH, Kaski, JC, Rosano, GMC, Tautermann, G, Huber, K, Dopheide, JF, Mader, A, Niessner, A, Savarese, G, Schmidt, TA, Semb, AG, Tamargo, J, Wassmann, S, Clodi, M, Kjeldsen, KP & Agewall, S 2022, 'Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy', European heart journal. Cardiovascular pharmacotherapy, vol. 8, no. 3, pvab048, pp. 302-310. https://doi.org/10.1093/ehjcvp/pvab048

@article{ffc66dd719064dacbc04b3cccd48ee27,

title = "Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy",

keywords = "Randomized clinical trials, Subgroup analyses, Cardiovascular pharmacotherapy, Humans, Cardiovascular System, Randomized Controlled Trials as Topic",

author = "Heinz Drexel and Pocock, {Stuart J} and Lewis, {Basil S} and Saely, {Christoph H} and Kaski, {Juan Carlos} and Rosano, {Giuseppe M C} and Gerda Tautermann and Kurt Huber and Dopheide, {Joern F} and Arthur Mader and Alexander Niessner and Gianluigi Savarese and Schmidt, {Thomas A} and Semb, {Anne Grete} and Juan Tamargo and Sven Wassmann and Martin Clodi and Kjeldsen, {Keld Per} and Stefan Agewall",

year = "2022",

month = may,

day = "5",

doi = "10.1093/ehjcvp/pvab048",

language = "English",

volume = "8",

pages = "302--310",

journal = "European Heart Journal - Cardiovascular Pharmacotherapy",

issn = "2055-6837",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Subgroup analyses in randomized clinical trials

T2 - Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

AU - Drexel, Heinz

AU - Pocock, Stuart J

AU - Lewis, Basil S

AU - Saely, Christoph H

AU - Kaski, Juan Carlos

AU - Rosano, Giuseppe M C

AU - Tautermann, Gerda

AU - Huber, Kurt

AU - Dopheide, Joern F

AU - Mader, Arthur

AU - Niessner, Alexander

AU - Savarese, Gianluigi

AU - Schmidt, Thomas A

AU - Semb, Anne Grete

AU - Tamargo, Juan

AU - Wassmann, Sven

AU - Clodi, Martin

AU - Kjeldsen, Keld Per

AU - Agewall, Stefan

PY - 2022/5/5

Y1 - 2022/5/5

KW - Randomized clinical trials

KW - Subgroup analyses

KW - Cardiovascular pharmacotherapy

KW - Humans

KW - Cardiovascular System

KW - Randomized Controlled Trials as Topic

UR - http://www.scopus.com/inward/record.url?scp=85129998085&partnerID=8YFLogxK

U2 - 10.1093/ehjcvp/pvab048

DO - 10.1093/ehjcvp/pvab048

M3 - Review

C2 - 34180504

VL - 8

SP - 302

EP - 310

JO - European Heart Journal - Cardiovascular Pharmacotherapy

JF - European Heart Journal - Cardiovascular Pharmacotherapy

SN - 2055-6837

IS - 3

M1 - pvab048

ER -

Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

Keywords

Access to Document

Other files and links

Cite this